FILE:STJ/STJ-8K-20081126170027.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 21, 2008
 
ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
 
 
Registrant's telephone number, including area code
(651) 483-2000
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
(b)   On November 21, 2008, Joseph McCullough, Group President of St. Jude Medical, Inc. ("the Company"), was appointed on an interim basis to the additional role of Interim President of the United States Division of the Company, effective immediately. He succeeds George Fazio, who notified the Company on November 21, 2008 that, for personal reasons, he was stepping down from the role as President of the United States Division of the Company, effective immediately. Mr. Fazio is transitioning to a different role within the Company's Corporate Division based in St. Paul, Minnesota.
 
SIGNATURE
 
          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 


